Status:
COMPLETED
Anesthetic Management and Remote Reperfusion Injuries
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Heart Valve Diseases
Eligibility:
All Genders
20-75 years
Brief Summary
Ischemia- reperfusion ( IR ) injuries were not only seen in the transplanted organs but also the remote organs such as lungs that brings major postoperative complications. Severe complications such as...
Detailed Description
Seven ml blood sample were taken from arterial line after stabilization of anesthesia (T1), 30 minutes after total CPB (T2), one hour after weaning from CPB (T3) and 24 hours after weaning from CPB (T...
Eligibility Criteria
Inclusion
- age \> 20 y/0, need cardiopulmonary bypass
Exclusion
- severe anemia, hematologic diseases, hormone therapy, previous valvular surgery, blood transfusion in recent 3 months
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00745810
Start Date
August 1 2008
End Date
December 1 2010
Last Update
October 17 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taipei, Taiwan, 100